Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis

Alessandro Casini,Lorenzo Alberio,Anne Angelillo-Scherrer,Pierre Fontana,Bernhard Gerber,Lukas Graf,Inga Hegemann,Wolfgang Korte,Johanna A. Kremer Hovinga,Thomas Pierre Lecompte,Maria Martinez,Michael Nagler,Jan-Dirk Studt,Dimitrios A. Tsakiris,Walter A. Wuillemin,Lars M. Asmis

Thromboprophylaxis and laboratory monitoring for in-hospital patients with COVID-19 - a Swiss consensus statement by the Working Party Hemostasis

2020

Alessandro Casini
Lorenzo Alberio
Anne Angelillo-Scherrer
Pierre Fontana
Bernhard Gerber
Lukas Graf
Inga Hegemann
Wolfgang Korte
Johanna A. Kremer Hovinga
Thomas Pierre Lecompte
Maria Martinez
Michael Nagler
Jan-Dirk Studt
Dimitrios A. Tsakiris
Walter A. Wuillemin
Lars M. Asmis

Based on the available literature and published recommendations from international societies, the Working Party on Hemostasis (Swiss Society of Hematology) has prepared recommendations for pharmacological thromboprophylaxis in COVID-19 patients in the acute setting.

Keywords:

Intensive care medicine
2019 20 coronavirus outbreak
Coronavirus disease 2019
Medicine
severe acute respiratory syndrome coronavirus 2
Hemostasis
hospital patients
Coronavirus Infections
laboratory monitoring

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations